Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Summary for Patients
space
 arrow  Summary for Patients (PDF)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Published comments/rapid response letters
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Watson, J. T.
space
  arrow  Gerber, S. I.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Clinical Characteristics and Functional Outcomes of West Nile Fever

right arrow John T. Watson, MD, MSc; Peter E. Pertel, MD, MPH; Roderick C. Jones, MPH; Alicia M. Siston, MPH; William S. Paul, MD, MPH; Constance C. Austin, DVM, PhD, MPH; and Susan I. Gerber, MD

7 September 2004 | Volume 141 Issue 5 | Pages 360-365

Background: West Nile fever, considered a nonsevere manifestation of West Nile virus infection, has not been clinically well described in the United States. In 2002, Illinois had 884 documented cases of West Nile virus infection with 66 associated deaths.

Objective: To describe the symptoms and functional outcomes of West Nile fever.

Design: Case series.

Setting: Illinois.

Patients: 98 community-dwelling patients with laboratory evidence of West Nile virus infection but no history of clinical evidence of meningitis, encephalitis, or acute flaccid paralysis.

Intervention: Outpatient interviews.

Measurements: Presence and duration of patient-reported symptoms of infection, symptom-associated absenteeism, health care use, and impact on daily activities.

Results: Of 98 patients, 96% had fatigue for a median of 36 days, 81% had fever for a median of 5 days, 71% had headache for a median of 10 days, 61% had muscle weakness for a median of 28 days, and 53% had difficulty concentrating for a median of 14 days. Thirty respondents reported hospitalization, with a median stay of 5 days. At 30 days after onset, 63% of respondents continued to have symptoms. Duration did not vary significantly with increased age. Among the 72 patients who normally attended work or school, 57 (79%) could not attend because of illness (median absence, 10 days).

Limitations: Recall bias could have been introduced by the delay between illness onset and interview and by self-reporting of illness information.

Conclusions: West Nile fever is a more severe illness than has previously been documented. Mandatory reporting of West Nile fever cases in addition to West Nile meningoencephalitis cases could allow more accurate and timely recognition of the geographic distribution of West Nile virus infections and could inform public health interventions.


Editors' Notes
space

Context

  • The frequency of infection with West Nile virus is increasing rapidly in the United States. While the most fatal and closely studied manifestations of the disease are meningitis and encephalitis, little is known about the symptoms and clinical outcomes of West Nile fever.

Contribution

  • The authors interviewed 98 people with nonparalytic West Nile fever following recovery. Muscle weakness, fatigue, headache, difficulty concentrating, and fever were common manifestations. Approximately one third of patients required hospitalization. Median time to full recovery was 60 days.

Implications

  • Even in the absence of neurologic manifestations, West Nile virus infection is a potentially severe and debilitating illness.

–The Editors

 

Author and Article Information
space

From Chicago Department of Public Health, Chicago, and Illinois Department of Public Health, Springfield, Illinois; and Centers for Disease Control and Prevention, Atlanta, Georgia.

Potential Financial Conflicts of Interest: None disclosed.

Corresponding Author: John T. Watson, MD, Chicago Department of Public Health, 2160 West Ogden, Chicago, IL 60612; e-mail, watson_john{at}cdph.org.

Current Author Addresses: Drs. Watson, Paul, and Gerber, Mr. Jones, and Ms. Siston: Chicago Department of Public Health, 2160 West Ogden, Chicago, IL 60612.

Dr. Pertel: Bayer Pharmaceuticals, 400 Morgan Lane, West Haven, CT 06516.

Dr. Austin: Illinois Department of Public Health, 525 West Jefferson Street, Springfield, IL 62761.

Author Contributions: Conception and design: J.T. Watson, P.E. Pertel, R.C. Jones, W.S. Paul, S.I. Gerber.

Analysis and interpretation of the data: J.T. Watson, P.E. Pertel, R.C. Jones, A.M. Siston, S.I. Gerber.

Drafting of the article: J.T. Watson, P.E. Pertel, R.C. Jones.

Critical revision of the article for important intellectual content: J.T. Watson, P.E. Pertel, R.C. Jones, A.M. Siston, W.S. Paul, C.C. Austin, S.I. Gerber.

Final approval of the article: J.T. Watson, P.E. Pertel, R.C. Jones, A.M. Siston, W.S. Paul, C.C. Austin, S.I. Gerber.

Provision of study materials or patients: C.C. Austin.

Statistical expertise: R.C. Jones, A.M. Siston.

Collection and assembly of data: J.T. Watson, P.E. Pertel.


Related articles in Annals:

Summaries for Patients
Clinical Characteristics and Consequences of West Nile Fever
Annals 2004 141: I-53. [Full Text]  



This article has been cited by other articles:


Home page
Clin. Chem.Home page
N. A. Shaikh, J. Ge, Y.-X. Zhao, P. Walker, and M. Drebot
Development of a novel, rapid, and sensitive immunochromatographic strip assay specific for West Nile Virus (WNV) IgM and testing of its diagnostic accuracy in patients suspected of WNV infection.
Clin. Chem., November 1, 2007; 53(11): 2031 - 2034.
[Full Text] [PDF]


Home page
JAMAHome page
West Nile Virus Activity United States, 2006
JAMA, August 8, 2007; 298(6): 619 - 621.
[Full Text] [PDF]


Home page
J. Virol.Home page
M. A. Samuel and M. S. Diamond
Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion
J. Virol., October 1, 2006; 80(19): 9349 - 9360.
[Full Text] [PDF]


Home page
JAMAHome page
West Nile Virus Activity--United States, January 1-December 1, 2005
JAMA, January 18, 2006; 295(3): 266 - 267.
[Full Text] [PDF]


Home page
Am J Trop Med HygHome page
G. D. HUHN, C. AUSTIN, C. LANGKOP, K. KELLY, R. LUCHT, R. LAMPMAN, R. NOVAK, L. HARAMIS, R. BOKER, S. SMITH, et al.
THE EMERGENCE OF WEST NILE VIRUS DURING A LARGE OUTBREAK IN ILLINOIS IN 2002
Am J Trop Med Hyg, June 1, 2005; 72(6): 768 - 776.
[Abstract] [Full Text] [PDF]


Home page
JWatch Infect. DiseasesHome page
Clinical Characteristics of West Nile Fever
Journal Watch Infectious Diseases, October 25, 2004; 2004(1025): 5 - 5.
[Full Text]

Rapid Responses:

Read all Rapid Responses

A Plea for Clinical Clarity: If West Nile Encephalitis is Caused by West Nile Virus, then what is WN
Burke A. Cunha
Annals Online, 27 Oct 2004 [Full text]



 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2004 by the American College of Physicians.